microFAST Dx

microFAST Dx is a rapid diagnostics company that specializes in upstream sample collection and processing technologies designed to facilitate decentralized diagnostics. The company develops microscale sample processing devices, such as its RapiSep plasma separation technology, which simplifies sample preparation workflows by converting blood to plasma. These devices are intended to function either as standalone tools or as interfaces for downstream analysis, aiming to bridge the gap between initial sample collection and final testing.

By focusing on user-friendly, portable solutions, microFAST Dx seeks to empower in vitro diagnostics (IVD) developers to offer blood testing that can be performed by individuals with minimal training in various settings, including at home or at point-of-care locations. The company's technology is designed to expand the accessibility of rapid blood tests for applications such as health and wellness monitoring, chronic disease management, and acute infection testing. microFAST Dx operates as a wholly owned entity of Zymeron Corporation.